• Globe Newswire

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.

Globenewswire -

• Globe Newswire

Bioptimus Assembles Elite Scientific Advisory Board to Build Next-Gen AI Models for Biology

Globenewswire -

• Globe Newswire

AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer

Globenewswire -

• Globe Newswire

Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation

Globenewswire -

• Globe Newswire

Olon Group Announces the Acquisition of GTP Bioways Group

• Globe Newswire

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

• Globe Newswire

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer